Researchers were able to estimate the number of active hematopoietic stem cells based on the number of somatic mutations present.
Researchers in Japan being a new trial of induced pluripotent stem cells to treat Parkinson's disease, Science reports.
The two studies used Drop-seq RNA profiling to discover essentially all cell types and establish cell lineages in a model organism flatworm.
Kyoto University investigator has been fired for research misconduct, while Nobel Laureate Shinya Yamanaka has been penalized for lack of oversight, Retraction Watch reports.
In PNAS this week: a DNA repair map for Saccharomyces cerevisiae, an in vitro method for genetic mapping in hybrid mammals, and more.
As the California Institute for Regenerative Medicine runs out of funds, NPR asks whether states will again fund stem cell research.
A Kyoto University investigation finds a researcher guilty of manipulating image data in a stem cell paper, Retraction Watch reports.
The companies will offer CDI's human induced pluripotent stem cell-derived tissue cells with Nanion's ion channel drug discovery and screening platform.
In Nature this week: variability in iPSCs, the silver birch, and more.
Researchers profiled the genotypes and phenotypes for more than 700 induced pluripotent stem cell lines, uncovering between-individual sources of variation.
The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.
The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.
Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.
In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.